ENTELLIGENCE is a program for basic science, translational, and clinical research in the field of cardiopulmonary medicine.
The program provides opportunities for individual young investigators to promote quality medical care and enhance patients' lives by supporting research in pulmonary hypertension (PH) related to expanding our knowledge of the pathways involved in pulmonary vascular pathobiology.
Sign Up For Reminder Alerts
All 2016-2017 grant submissions are being evaluated by the ENTELLIGENCE Steering Committee. Applicants selected by the Steering Committee, and those whose projects were not selected, will be notified via emal. Notification will be sent by March 20, 2017.
The ENTELLIGENCETM Young Investigator program is supported through an educational grant from Actelion Pharmaceuticals US, Inc.